La stratificazione del rischio, aritmico dopo infarto miocardico acuto

Translated title of the contribution: Arrhythmic risk stratification after acute myocardial infarction

Research output: Contribution to journalArticle

Abstract

Recent studies clearly support the role of the cardioverter implantable defibrillator in reducing arrhythmic and all-cause mortality in patients with a previous myocardial infarction. However, the use of the cardioverter implantable defibrillator cannot be extended to all myocardial infarction patients despite its effectiveness because implantation is an invasive procedure and the cost of the device is high. Thus, the correct and effective identification of patients at high risk of life-threatening ventricular arrhythmias represents a clinically relevant problem owing to the availability of an effective but expensive therapeutic tool. Many non-invasive tests have been studied in past years to assess the risk of ventricular arrhythmias after myocardial infarction; moreover, also programmed ventricular stimulation has been used to evaluate inducibility of ventricular tachycardia. Nevertheless, the positive predictive value of both non-invasive and invasive testing is low and not adequate to make a clinical decision. This finding is probably related to the multifactorial genesis of malignant ventricular arrhythmias which need several concomitant factors to trigger arrhythmias. For this reason the combined use of multiple risk markers is needed in order to improve diagnostic accuracy and identify subgroups of patients at high enough risk to define specific prophylactic options. In this scenario, according to available data, patients with two or more non-invasive risk markers should undergo electrophysiologic testing. In fact, patients with a recent myocardial infarction who have positive non-invasive tests and also show inducibility of sustained monomorphic ventricular tachycardia at programmed ventricular stimulation have a high incidence of arrhythmic events during the subsequent follow-up period and, in the author's opinion, should undergo a cardioverter defibrillator implantation. In the present review, an analysis of the main diagnostic tests for risk stratification of postinfarction patients will be performed and operative suggestions will be provided.

Original languageItalian
Pages (from-to)1123-1137
Number of pages15
JournalItalian Heart Journal Supplement
Volume1
Issue number9
Publication statusPublished - 2000

Fingerprint

Myocardial Infarction
Cardiac Arrhythmias
Implantable Defibrillators
Ventricular Tachycardia
Defibrillators
Routine Diagnostic Tests
Costs and Cost Analysis
Equipment and Supplies
Mortality
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

La stratificazione del rischio, aritmico dopo infarto miocardico acuto. / Pedretti, R. F E.

In: Italian Heart Journal Supplement, Vol. 1, No. 9, 2000, p. 1123-1137.

Research output: Contribution to journalArticle

@article{18b2ce7864d3461fb7993c46574c48bd,
title = "La stratificazione del rischio, aritmico dopo infarto miocardico acuto",
abstract = "Recent studies clearly support the role of the cardioverter implantable defibrillator in reducing arrhythmic and all-cause mortality in patients with a previous myocardial infarction. However, the use of the cardioverter implantable defibrillator cannot be extended to all myocardial infarction patients despite its effectiveness because implantation is an invasive procedure and the cost of the device is high. Thus, the correct and effective identification of patients at high risk of life-threatening ventricular arrhythmias represents a clinically relevant problem owing to the availability of an effective but expensive therapeutic tool. Many non-invasive tests have been studied in past years to assess the risk of ventricular arrhythmias after myocardial infarction; moreover, also programmed ventricular stimulation has been used to evaluate inducibility of ventricular tachycardia. Nevertheless, the positive predictive value of both non-invasive and invasive testing is low and not adequate to make a clinical decision. This finding is probably related to the multifactorial genesis of malignant ventricular arrhythmias which need several concomitant factors to trigger arrhythmias. For this reason the combined use of multiple risk markers is needed in order to improve diagnostic accuracy and identify subgroups of patients at high enough risk to define specific prophylactic options. In this scenario, according to available data, patients with two or more non-invasive risk markers should undergo electrophysiologic testing. In fact, patients with a recent myocardial infarction who have positive non-invasive tests and also show inducibility of sustained monomorphic ventricular tachycardia at programmed ventricular stimulation have a high incidence of arrhythmic events during the subsequent follow-up period and, in the author's opinion, should undergo a cardioverter defibrillator implantation. In the present review, an analysis of the main diagnostic tests for risk stratification of postinfarction patients will be performed and operative suggestions will be provided.",
keywords = "Myocardial infarction, Prognosis, Sudden cardiac death",
author = "Pedretti, {R. F E}",
year = "2000",
language = "Italian",
volume = "1",
pages = "1123--1137",
journal = "Italian Heart Journal Supplement",
issn = "1129-4728",
publisher = "Centro Editoriale Pubblicitario Italiano",
number = "9",

}

TY - JOUR

T1 - La stratificazione del rischio, aritmico dopo infarto miocardico acuto

AU - Pedretti, R. F E

PY - 2000

Y1 - 2000

N2 - Recent studies clearly support the role of the cardioverter implantable defibrillator in reducing arrhythmic and all-cause mortality in patients with a previous myocardial infarction. However, the use of the cardioverter implantable defibrillator cannot be extended to all myocardial infarction patients despite its effectiveness because implantation is an invasive procedure and the cost of the device is high. Thus, the correct and effective identification of patients at high risk of life-threatening ventricular arrhythmias represents a clinically relevant problem owing to the availability of an effective but expensive therapeutic tool. Many non-invasive tests have been studied in past years to assess the risk of ventricular arrhythmias after myocardial infarction; moreover, also programmed ventricular stimulation has been used to evaluate inducibility of ventricular tachycardia. Nevertheless, the positive predictive value of both non-invasive and invasive testing is low and not adequate to make a clinical decision. This finding is probably related to the multifactorial genesis of malignant ventricular arrhythmias which need several concomitant factors to trigger arrhythmias. For this reason the combined use of multiple risk markers is needed in order to improve diagnostic accuracy and identify subgroups of patients at high enough risk to define specific prophylactic options. In this scenario, according to available data, patients with two or more non-invasive risk markers should undergo electrophysiologic testing. In fact, patients with a recent myocardial infarction who have positive non-invasive tests and also show inducibility of sustained monomorphic ventricular tachycardia at programmed ventricular stimulation have a high incidence of arrhythmic events during the subsequent follow-up period and, in the author's opinion, should undergo a cardioverter defibrillator implantation. In the present review, an analysis of the main diagnostic tests for risk stratification of postinfarction patients will be performed and operative suggestions will be provided.

AB - Recent studies clearly support the role of the cardioverter implantable defibrillator in reducing arrhythmic and all-cause mortality in patients with a previous myocardial infarction. However, the use of the cardioverter implantable defibrillator cannot be extended to all myocardial infarction patients despite its effectiveness because implantation is an invasive procedure and the cost of the device is high. Thus, the correct and effective identification of patients at high risk of life-threatening ventricular arrhythmias represents a clinically relevant problem owing to the availability of an effective but expensive therapeutic tool. Many non-invasive tests have been studied in past years to assess the risk of ventricular arrhythmias after myocardial infarction; moreover, also programmed ventricular stimulation has been used to evaluate inducibility of ventricular tachycardia. Nevertheless, the positive predictive value of both non-invasive and invasive testing is low and not adequate to make a clinical decision. This finding is probably related to the multifactorial genesis of malignant ventricular arrhythmias which need several concomitant factors to trigger arrhythmias. For this reason the combined use of multiple risk markers is needed in order to improve diagnostic accuracy and identify subgroups of patients at high enough risk to define specific prophylactic options. In this scenario, according to available data, patients with two or more non-invasive risk markers should undergo electrophysiologic testing. In fact, patients with a recent myocardial infarction who have positive non-invasive tests and also show inducibility of sustained monomorphic ventricular tachycardia at programmed ventricular stimulation have a high incidence of arrhythmic events during the subsequent follow-up period and, in the author's opinion, should undergo a cardioverter defibrillator implantation. In the present review, an analysis of the main diagnostic tests for risk stratification of postinfarction patients will be performed and operative suggestions will be provided.

KW - Myocardial infarction

KW - Prognosis

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=0033744683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033744683&partnerID=8YFLogxK

M3 - Articolo

C2 - 11140281

AN - SCOPUS:0033744683

VL - 1

SP - 1123

EP - 1137

JO - Italian Heart Journal Supplement

JF - Italian Heart Journal Supplement

SN - 1129-4728

IS - 9

ER -